Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Knowing what to avoid in cryptocurrency investments can save you from costly errors. Stay informed to protect your assets.
16,150 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Two powerhouse ideas could propel your portfolio toward the next decade: a campus-wide AI infrastructure leader and a...
A controversial proposal has sparked a fierce debate among developers, miners, and industry leaders. This article unp...
Markets keep climbing amid strong earnings and AI-led investment. This article explains why this bull market crushing...
Berkshire Hathaway’s surprise Alphabet investment signals a bold, long-term bet from Buffett. Learn the reasoning, ri...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
With earnings approaching, investors wonder if Extra Space Storage stock can deliver reliable income and resilience. ...
A rally in AeroVironment shares has investors wondering what sparked the move. This guide breaks down the factors beh...
A veteran recruiter describes a rising problem: casual Zoom interviews with bathrobe moments and AI-assisted answers....
Bitcoin trades below $65k, yet Polymarket participants are betting on a $150k price by year-end 2026. This article ex...
As markets enter 2026, a century of stock market data underpins a new wave of strategy. This piece distills three les...
Nvidia’s CEO just handed investors a fresh signal about AI demand and Nvidia’s path forward. This guide breaks down t...